Search Results - "Fischer, J S"

The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment by Fischer, J S, Rudick, R A, Cutter, G R, Reingold, S C

“…Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales…”
Get full text

ICF-based multidisciplinary rehabilitation program for complex regional pain syndrome of the hand: efficacy, long-term outcomes, and impact of therapy duration by Kotsougiani-Fischer, D, Choi, J S, Oh-Fischer, J S, Diehm, Y F, Haug, V F, Harhaus, L, Gazyakan, E, Hirche, C, Kneser, U, Fischer, S

“…Complex regional pain syndrome (CRPS) is a rare but feared complication in hand surgery. Although multimodal therapy concepts are recommended, there is only…”
Get full text

Recent developments in the assessment of quality of life in Multiple Sclerosis (MS) by Fischer, J S, LaRocca, N G, Miller, D M, Ritvo, P G, Andrews, H, Paty, D

“…Multiple sclerosis (MS) and its treatment have broad-ranging effects on quality of life. This article reviews recent efforts to assess the impact of MS on…”
Get full text

Effect of chronic morphine on the dentate gyrus neurogenic microenvironment by Arguello, A.A, Fischer, S.J, Schonborn, J.R, Markus, R.W, Brekken, R.A, Eisch, A.J

“…Abstract Opiates, such as morphine, decrease neurogenesis in the postnatal hippocampal subgranular zone (SGZ) by inhibiting progenitor proliferation and…”
Get full text

Development of a multiple sclerosis functional composite as a clinical trial outcome measure by Cutter, Gary R., Baier, Monika L., Rudick, Richard A., Cookfair, Diane L., Fischer, Jill S., Petkau, John, Syndulko, Karl, Weinshenker, Brian G., Antel, Jack P., Confavreux, Christian, Ellison, George W., Lublin, Fred, Miller, Aaron E., Rao, Stephen M., Reingold, Stephen, Thompson, Alan, Willoughby, Ernest

“…The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New…”
Get full text

Morphine blood levels, dependence, and regulation of hippocampal subgranular zone proliferation rely on administration paradigm by Fischer, S.J, Arguello, A.A, Charlton, J.J, Fuller, D.C, Zachariou, V, Eisch, A.J

“…Abstract Chronic morphine, administered via s.c. pellet, decreases the number of proliferating cells in the dentate gyrus subgranular zone (SGZ) in both rats…”
Get full text

The Book of Jeremiah : realisation of threats of the Torah – and also of promises? by Fischer SJ, Georg

“…The relationship between the Torah and the Prophets has been a matter of dispute. This article discusses the links of the Book of Jeremiah especially with the…”
Get full text

A longitudinal study of brain atrophy in relapsing multiple sclerosis by SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Get full text

Intrarater and interrater reliability of the MS functional composite outcome measure by COHEN, J. A, FISCHER, J. S, BOLIBRUSH, D. M, JAK, A. J, KNIKER, J. E, MERTZ, L. A, SKARAMAGAS, T. T, CUTTER, G. R

“…To assess practice effects, and intrarater and interrater reliability of the MS functional composite (MSFC) outcome measure. To address the poor reliability…”
Get full text

Assessing depressive symptoms in multiple sclerosis : Is it necessary to omit items from the original beck depression inventory? by AIKENS, J. E, REINECKE, M. A, PLISKIN, N. H, FISCHER, J. S, WIEBE, J. S, MCCRACKEN, L. M, TAYLOR, J. L

“…Overlap between depression scale item content and medical symptoms may exaggerate depression estimates for patients with multiple sclerosis (MS). We reconsider…”
Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis by AIKENS, J. E, FISCHER, J. S, NAMEY, M, RUDICK, R. A

“…Life stress and coping responses jointly contribute to psychological adjustment in many chronic illness populations, but their significance in multiple…”
Get full text

Benefit of interferon β-1a on MSFC progression in secondary progressive MS by COHEN, J. A, CUTTER, G. R, TSAO, E. C, WHITAKER, J. N, FISCHER, J. S, GOODMAN, A. D, HEIDENREICH, F. R, KOOIJMANS, M. F, SANDROCK, A. W, RUDICK, R. A, SIMON, J. H, SIMONIAN, N. A

Get full text

Inhibition of axonal growth from sensory neurons by excess nerve growth factor by Conti, A M, Fischer, S J, Windebank, A J

“…Fifteen-day embryonic rat dorsal root ganglion (DRG) neurons were exposed to 1 to 200 ng/ml nerve growth factor (NGF). Maximal neurite outgrowth was obtained…”
Get more information

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS by Cohen, J A, Cutter, G R, Fischer, J S, Goodman, A D, Heidenreich, F R, Kooijmans, M F, Sandrock, A W, Rudick, R A, Simon, J H, Simonian, N A, Tsao, E C, Whitaker, J N

“…Interferon beta-1a (IFNbeta-1a, Avonex) is efficacious in relapsing forms of MS. Studies of other IFNbeta preparations in secondary progressive MS (SPMS)…”
Get full text

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients by Jabri, N., Schalch, D. S., Schwartz, S. L., Fischer, J. S., Kipnes, M. S., Radnik, B. J., Turman, N. J., Marcsisin, V. S., Guler, H. P.

“…Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. N Jabri , D S Schalch , S L Schwartz ,…”
Get full text

A longitudinal study of T1 hypointense lesions in relapsing MS : MSCRG trial of interferon β-1a by SIMON, J. H, LULL, J, MCCABE, K, SERRA, A, CAMPION, M. K, FISCHER, J. S, GOODKIN, D. E, SIMONIAN, N, LAJAUNIE, M, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, JACOBS, L. D, MUNSCHAUER, F. E, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, SHEEDER, J, MILLER, D

Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis: Multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

Epstein-Barr virus DNA associated with gastric adenocarcinoma and adjacent non-cancerous mucosa in patients from Manaus, Brazil by de Aquino, P F, Carvalho, P C, da Gama Fischer, J S, de Souza, A Q L, Viana, J S, Chalub, S R S, de Souza, A D L, Carvalho, M G C

“…Gastric cancer is one of most frequent causes of death in Brazil. The city of Manaus has one of the highest incidences of this disease in Brazil. The…”
Get full text

Alterations in Cell Cycle Regulation Underlie Cisplatin Induced Apoptosis of Dorsal Root Ganglion Neurons in Vivo by Fischer, Stephanie J., McDonald, Elizabeth S., Gross, LouAnn, Windebank, Anthony J.

“…Cisplatin is used in the treatment of ovarian and testicular cancer. Twenty percent of patients cannot be optimally treated because of sensory neurotoxicity…”
Get full text